| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/15/1999 | WO1999005300A3 Ghrh expression system and methods of use |
| 04/15/1999 | WO1999005266A3 Trans-species nuclear transfer |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999004041A9 Methods and compositions for modulating melting temperatures of nucleic acids |
| 04/15/1999 | WO1999004016A3 Proteases from gram-positive organisms |
| 04/15/1999 | WO1999003872A9 Nucleic acid ladders |
| 04/15/1999 | WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 04/15/1999 | WO1999002655A9 Protein kinases and uses thereof |
| 04/15/1999 | WO1999002647A3 Cloning vectors for producing adenoviral minimal viruses |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | WO1999001476A9 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN |
| 04/15/1999 | WO1999000487A9 Methods and tissue culture media for inducing somatic embryogenesis, agrobacterium-mediated transformation and efficient regeneration of cacao plants |
| 04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |
| 04/15/1999 | WO1999000145A9 Antigenic modulation of viral particules |
| 04/15/1999 | WO1999000010A3 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 04/15/1999 | WO1998059360A9 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/15/1999 | WO1998059061A9 Male tissue-preferred regulatory region and method of using same |
| 04/15/1999 | WO1998059058A3 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/15/1999 | WO1998059050A9 Cloning of a gene mutation for parkinson's disease |
| 04/15/1999 | WO1998059048A9 Receptor for a bacillus thuringiensis toxin |
| 04/15/1999 | WO1998058945A9 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 04/15/1999 | WO1998056943A9 Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998047343A9 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages |
| 04/15/1999 | WO1998046645A3 Method for the production of antihuman antigen receptors and uses thereof |
| 04/15/1999 | WO1998045429A3 Polypeptides involved in the staurosporine induced apoptotic pathway |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | WO1998043993A3 Nucleic acid catalysts |
| 04/15/1999 | DE19744655A1 Antibody specific for baculovirus, for detection of baculovirus |
| 04/15/1999 | DE19744212A1 Verfahren zur Herstellung von Ergosterol und dessen Zwischenstufen mittels rekombinanter Hefen A process for producing ergosterol and its intermediates by recombinant yeasts |
| 04/15/1999 | DE19743518A1 Automatisierbare universell anwendbare Probenvorbereitungsmethode Automated sample preparation method universally applicable |
| 04/15/1999 | DE19742706A1 Anticaline Anticalins |
| 04/15/1999 | CA2309791A1 Plant fatty acid hydroxylase genes |
| 04/15/1999 | CA2308126A1 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2308120A1 Human proteins having transmembrane domains and cdnas encoding these proteins |
| 04/15/1999 | CA2308004A1 Multiple displacement amplification |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2306182A1 Gene deleted recombinant felv proviral dna for production of vaccines against felv |
| 04/15/1999 | CA2305886A1 Human proteins having transmembrane domains and cdnas encoding these proteins |
| 04/15/1999 | CA2305848A1 Cdnas coding for human proteins having transmembrane domains |
| 04/15/1999 | CA2305815A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 04/15/1999 | CA2305814A1 Gankyrin |
| 04/15/1999 | CA2305785A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | CA2305782A1 Method for producing branched fatty acids using genetically modified plants |
| 04/15/1999 | CA2305712A1 Natural humanized antibody |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305708A1 A keratinocyte derived protease |
| 04/15/1999 | CA2305707A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit |
| 04/15/1999 | CA2305689A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305682A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | CA2305577A1 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 04/15/1999 | CA2305573A1 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample |
| 04/15/1999 | CA2305559A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 04/15/1999 | CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | CA2305386A1 Proteins alike to human complement factor h and cdnas encoding these proteins |
| 04/15/1999 | CA2305382A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | CA2305337A1 Human proteins having secretory signal sequences and cdnas encoding these proteins |
| 04/15/1999 | CA2305267A1 Control of nucleic acid amplification procedures including the polymerase chain reaction (pcr) |
| 04/15/1999 | CA2305204A1 Yeast cells expressing modified g proteins and methods of use therefor |
| 04/15/1999 | CA2305045A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
| 04/15/1999 | CA2304803A1 Protein delivery by secretory gland expression |
| 04/15/1999 | CA2304798A1 Combinatorial antisense library |
| 04/15/1999 | CA2304796A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304350A1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | CA2273842A1 A human 2-19 protein homologue, z219a |
| 04/15/1999 | CA2273195A1 Icam-4 and diagnostic uses thereof |
| 04/14/1999 | EP0908727A1 Synuclein-based assay and synuclein protein |
| 04/14/1999 | EP0908521A1 Transfection system for the transfer of nucleic acids into cells |
| 04/14/1999 | EP0908520A2 Maleate isomerase gene |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908518A2 MurE gene encoding uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase of Streptococcus pneumoniae |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908516A1 ABC transporter |
| 04/14/1999 | EP0908515A2 Pancreatic polypeptide |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0908093A1 Model transgenic animal for interleukin-1 relevant diseases |
| 04/14/1999 | EP0907890A1 Device for contamination-free delivery and discharge of liquid |
| 04/14/1999 | EP0907889A1 Light-controlled electrokinetic assembly of particles near surfaces |
| 04/14/1999 | EP0907887A1 Engineering affinity ligands for macromolecules |
| 04/14/1999 | EP0907886A1 Retinoid x receptors and components of the basal transcription machinery |
| 04/14/1999 | EP0907753A2 Nucleic acid primers and probes for detecting chlamydia pneumoniae |
| 04/14/1999 | EP0907751A2 Dna, rna and a protein useful for detection of a mycobacterial infection |
| 04/14/1999 | EP0907750A1 Three-hybrid screening assay |
| 04/14/1999 | EP0907748A1 Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicity of a sample and the kinetics of the genetoxicity |
| 04/14/1999 | EP0907746A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0907745A1 Aspergillus porphobilinogen synthases and nucleic acids encoding same |
| 04/14/1999 | EP0907744A1 Fungal metallo protease genes |
| 04/14/1999 | EP0907743A1 Catalytic macro molecules having cdc25b like activity |
| 04/14/1999 | EP0907742A2 Cyclic nucleotide phosphodiesterase |
| 04/14/1999 | EP0907741A1 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis |
| 04/14/1999 | EP0907740A1 THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
| 04/14/1999 | EP0907739A1 Porcine retrovirus |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907737A1 Il-6 mutein |
| 04/14/1999 | EP0907736A2 Cc-type chemokines |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907734A2 GALANIN RECEPTOR GalR2 |